Aspen Shareholders Provides Earnings Guidance for the Year Ended June 30, 2018

Aspen Pharmacare Holdings Limited is the African leading pharmaceutical group. The group's products are primarily for the treatment of asthma, HIV, bacterial infections, gastro-intestinal, respiratory and inflammatory diseases. Net sales break down by family of products as follows: - pharmaceuticals (71.6%): anaesthetics products, thrombosis products, cytotoxic products, etc.; - other (28.4%): infant nutrition products and consumer products. At the end of June 2022, the group had 16 production sites worldwide.